Surgeons at Dubai Health have announced a groundbreaking achievement: the successful removal of the world's largest adrenal tumor at Dubai Hospital. Dubai Hospital's multidisciplinary approach to the surgery, which forms part of the emirate's first integrated academic health system, ensured the best possible outcome. The successful surgery also reflects Dubai Health's promise to put the Patient First. 

The 69-year-old patient, previously in good health, was referred to the hospital's emergency unit due to a massive abdominal mass discovered during a scan. Struggling with walking and breathing for months prior to surgery, the patient's condition necessitated immediate specialized care.

Specialists from various disciplines across Dubai Health gathered at Dubai Hospital to deduce the best course of action for the patient. The four-hour procedure was performed by a multidisciplinary team of experts from urology, oncology, radiology, interventional radiology, vascular surgery, general surgery, and anesthesia. Measuring 27 x 26 cm and weighing 9.4 kilograms, the tumor’s size and weight surpassed all previous records.

Dr. Fariborz Bagheri, Consultant Urologist at Dubai Hospital, who led the operation, highlighted the complexity and risks associated with the procedure. "Due to the tumor's size and its compression on vital structures, surgical intervention posed considerable challenges," stated Dr. Fariborz. "However, without intervention, the patient's survival was at high risk." 

Reflecting on the outcome, Dr. Fariborz expressed gratitude for the successful procedure, attributing it to the combined efforts of the medical and surgical teams. He further commented, "We are very thankful that the patient responded well to the surgery and has fully recovered."

Dr. Mariam Al Raeesi, CEO of Dubai Hospital, highlighted the collaborative efforts of the multidisciplinary team in deciding to proceed with the surgery. "After careful consideration and collaboration among our medical and surgical experts, it was agreed to undertake this complex procedure," Dr. Al Raeesi said. "The enormous success of the procedure is a huge testament to our medical staff here at Dubai Hospital, putting in practice our Patient First promise focused on delivering high-quality care for patients."

Dubai Hospital is one of the largest specialized tertiary hospitals in the UAE. As part of Dubai Health, the first integrated academic health system in Dubai, the hospital provides comprehensive services in all healthcare disciplines, relevant to the needs of the community.

A delegation from UMass Chan Medical School, Massachusetts’s first and only public academic health sciences center, recently visited Dubai Health, solidifying a new chapter in healthcare collaboration between the two organizations. The visit, marked by the signing of a Memorandum of Understanding (MOU), granted the delegation the opportunity to gain insight into Dubai’s first integrated academic health system, laying the groundwork for a productive partnership.

Inspired by UMass Chan’s reputation for impact through collaborative endeavour and aspiration to change the course of the history of disease, the partnership reflects a shared vision between the two academic health systems to advance health. Under the agreement, UMass Chan and Dubai Health will establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the two academic institutions, and drive transformative advancements for public health, both locally and globally.

Led by Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor at UMass Chan, the visit also included an opportunity for Dubai Health learners to gain insight into elective and residency program opportunities at UMass Chan.

Commenting on the partnership, Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated, “This collaboration presents an exciting opportunity to combine the strengths of two academic health organizations. By pooling our resources, capabilities, and expertise, we are well-positioned to advance the frontier of medical knowledge that better serves our communities. The visit has been incredibly productive, laying the foundation for meaningful collaboration anchored in our shared purpose of advancing health for humanity.”

Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor of UMass Chan commented “It is a privilege, along with a group of senior colleagues, to learn more about the breadth and depth of activity taking place at Dubai Health and to forge closer relationships with its leadership. The signing of an MOU between our respective institutions is an exciting development and provides UMass Chan and Dubai Health with a framework from which to pursue meaningful collaborations and exchanges, by partnering, we do hope to advance together on behalf of the communities that we serve.”

The UMass Chan delegation included Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor; Terence R. Flotte, MD, Provost, Dean, and Executive Deputy Chancellor; David D. McManus, MD, Chair, Department of Medicine; Anne Larkin, MD, Associate Professor of Surgery, Vice Provost, and Senior Associate Dean for Educational Affairs; Lisa Colombo, DNP, MHA, RN, Executive Vice Chancellor and CEO, ForHealth Consulting; Rebekah Diamond, JD, Executive Director, Business Strategy & Operational Excellence, ForHealth Consulting; Brendan Chisholm, Vice Chancellor of Management, Chief of Staff, Office of the Chancellor.

April 04, 2024, Dubai: Al Jalila Foundation, which leads the giving mission of Dubai Health, announced that Saeed Ahmed Lootah Charity Foundation has donated AED 15 million to support the development of the Hamdan Bin Rashid Cancer Hospital, Dubai's first integrated, comprehensive cancer hospital. This donation underscores Saeed Ahmed Lootah Charity Foundation's commitment to advancing sustainable charitable and humanitarian work and reinforcing Dubai's pioneering role in healthcare excellence.

Set to open in 2026, the hospital honors the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum, paying tribute to his lifetime of service to the nation and extraordinary global philanthropic activities that continue to touch the lives of many around the world. The hospital is being developed with the support of generous donations received from philanthropists, government and non-government organizations, UAE businesses and corporates.

Engineer Hussain Nasser Lootah, Member of the Board of Trustees of the Saeed Ahmed Lootah Charity Foundation, said: “Inspired by our visionary leadership, which has embedded philanthropy into its core humanitarian strategies, the Saeed Ahmed Lootah Charity Foundation, led by H.E. Lieutenant General Dhahi Khalfan Tamim, Chairman of the Board of Trustees, remains committed to social responsibility, education, and medical research support. We are pleased to contribute towards the Hamdan Bin Rashid Cancer Hospital, aligning our efforts with Al Jalila Foundation to ensure equitable and essential access to cancer care. This partnership reflects the core principles of our esteemed founder, Haj Saeed Ahmed Lootah, who championed education, healthcare, and scientific research. Our dedication extends beyond borders, encompassing local and global charitable and humanitarian endeavors."

Dr. Thani Al Mheriri, CEO of Education & Health at Saeed Ahmed Lootah Charity Foundation, said: “By joining hands, we aim to make a meaningful impact in the fight against cancer and advancing medical research. Our dedication to medical education and healthcare is deeply rooted in our legacy; Dubai Medical College for Girls, which was established forty years ago as the first institution for medical education for girls in the Gulf region, is now a prominent contributor to the healthcare landscape."

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Donor support is an integral part of our success in developing the Hamdan Bin Rashid Cancer Hospital. We are grateful to Saeed Ahmed Lootah Charity Foundation, which has committed to helping us support cancer patients and their families. The hospital will bring together cancer expertise and make an invaluable contribution to Dubai’s healthcare sector, putting patient care first.”

"Together, we are one step closer to establishing a center of excellence that will transform cancer care in the UAE." he added.

The 116-bed hospital will occupy 56,000 square meters. It will provide best-in-class outpatient, ambulatory and diagnostic services as well as inpatient and surgical services in a nurturing environment that features personalized patient care.

As part of Dubai Health, the first integrated academic health system in Dubai, the comprehensive cancer hospital will benefit from a multidisciplinary team, including specialized nursing, offering patients a full spectrum of care services in one location, from early diagnosis to treatment and supportive care. Aligning with Dubai Health’s Patient First promise, select treatments and services will be made available to patients in the comfort of their homes, ensuring an easy and accessible continuum of care.

For more information on Al Jalila Foundation and its programs, please visit:
https://www.aljalilafoundation.ae